The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Alspaugh Jonathan since 2021.
This trader's CIK number is 1868112.
At the time of last reporting, Alspaugh Jonathan was the Chief Financial Officer of Aeglea Biotherapeutics, Inc.. (stock ticker symbol AGLE).
Also see all insider trading activities at Aeglea Biotherapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | AGLE | 75,000 | $156,000 | 0 | $0 | 0 | $0 |
| 2021 | AGLE | 90,372 | $448,654 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-03-11 | AGLE | Buy | 75,000 | 2.08 | 156,000 |
| 2021-12-09 | AGLE | Buy | 50,000 | 3.72 | 186,000 |
| 2021-08-18 | AGLE | Buy | 7,200 | 6.72 | 48,398 |
| 2021-08-17 | AGLE | Buy | 23,392 | 6.50 | 151,977 |
| 2021-08-16 | AGLE | Buy | 9,780 | 6.37 | 62,279 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Alspaugh Jonathan (Chief Financial Officer of Aeglea Biotherapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.